title: Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results.
abstract: Recent studies have demonstrated some association between the renin-angiotensin system (RAS) activity and the development and progression of different entities as diabetes mellitus (DM) or chronic allograft nephropathy. To investigate these associations, we studied some gene polymorphisms of RAS in a group of renal transplant recipients. We retrospectively analyzed 42 patients who underwent a primary renal transplantation for 2 years. A subgroup of 23 patients (55%) was diagnosed with postransplant DM in accordance with American Diabetes Association 2001 criteria. We studied two RAS gene polymorphisms: the angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensinogen (AGTM235T). Genotyping was performed by DNA purification and amplification with a polymerase chain reaction technique. The distributions of genotypes were ACE DD, ID, II: 33%, 48%, 19%; and AGT TT, MT, MM: 15%, 45%, 40%, respectively. We observed a progressive loss in renal function measured by creatinine clearance (Cockroft) in D-allele carriers (DD+ID) between the first and the second transplantation year: 65.3 +/- 4.3 vs 59.8 +/- 4.6 mL/min (P = 0.02); that was not seen in II patients: 68.8 +/- 4.6 vs 68.4 +/- 4 mL/min (P = 0.87). Fifty percent of D-allele carriers developed DM vs 25% of non-D-allele carriers (P = 0.19). Eighty-three percent of homozygous patients for the AGT-TT allele developed DM vs 35% of non TT patients (P = 0.04). There were no significant differences regarding recipient demographic characteristics, type of donor, number and severity of acute rejections, and immunosuppressant treatment between the groups. In conclusion, ACE D-allele seems to be associated with a poorer kidney graft long-term outcome. ACE D and AGT T alleles may be implicated in glucose metabolism disorders after transplantation.
authors.affiliation: Department of Nephrology, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain. arodriguez@friat.es
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez-Moreno
authors.forename: A I
authors.initials: AI
authors.lastname: Sánchez-Fructuoso
authors.forename: N
authors.initials: N
authors.lastname: Ridao-Cano
authors.forename: N
authors.initials: N
authors.lastname: Calvo
authors.forename: J
authors.initials: J
authors.lastname: Conesa
authors.forename: F
authors.initials: F
authors.lastname: Gómez-Gallego
authors.forename: C
authors.initials: C
authors.lastname: Santiago
authors.forename: F
authors.initials: F
authors.lastname: Bandrés
authors.forename: A
authors.initials: A
authors.lastname: Barrientos
mesh_terms: D004247:DNA / Q000097:blood / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012084:Renin-Angiotensin System / Q000235:genetics*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D004247:DNA